Results from the 2023-2024 U.S. flu season show that in adults vaccine effectiveness against hospitalization ranged from 41% to 44%. Specifically for children and teens less than 18 years, the flu vaccine was 71% effective for preventing symptomatic influenza A illness. ...
It takes about 1-2 weeks after vaccination for antibodies against influenza to develop and provide protection. The CDC has published a summary list of their current recommendations of who should get the current vaccine. Summary of CDC influenza vaccination recommendations for 2023-2024 Updated CDC ...
“Approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility, and accessibility for individuals and families,” said Peter Marks, MD, PhD, the director...
2023-2024 Flu Season Predictions: What Can We Expect? Annual flu season patterns and trends have been in continual flux since 2020. See what may be in store for the 2023-2024 flu season Vaccines Updated Flu Vaccine Recommendations for the 2023-2024 Flu Season ...
Suitable for individuals aged 6 months or above Vaccination will begin on 1 September 2024What is inactivated influenza vaccine (IIV)? Q: What is inactivated influenza vaccine (IIV)? The inactivated influenza vaccine (IIV) contains inactivated (killed) viruses. It is usually produced by growing th...
The CDC recommends a flu vaccinefor nearly everyone six months and older in the U.S. every flu season, except for anyone younger than six months or anyone with a severe, life-threatening allergy to any ingredient in a vaccine or the flu vaccine specifically. ...
Information for HCPs about FluMist® (Influenza Vaccine Live, Intranasal) for flu protection in a nasal spray.
More information:Huong Q. McLean et al, Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness—Wisconsin, October 2022–February 2023,MMWR. Morbidity and Mortality Weekly Report(2023).DOI: 10.15585/mmwr.mm7208a1 Journal information:Morbidity and Mortality Weekly Report...
Vaccination: annual flu vaccine recommended for over 65s, children, healthcare workers, and high-risk groups. Introduction Influenza is a common viral infection of the upper and lower respiratory tract caused by the influenza family of viruses. It is an endemic infection which most commonly occurs...
FLUAD® with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.